Supported by

Stents, scaffolds and DCB

Find all the latest content on stents and scaffolds published on this website.

Since 1986, when the first cardiovascular stent was implanted, the development of drug-eluting stents (DES) and the recent introduction of bioresorbable scaffolds have revolutionised interventional cardiology. Keep up-to-date with the latest research; evolving tools, devices and techniques; the role of adjunctive pharmacotherapy; advances in imaging techniques as well as the use of invasive imaging and functional assessment. Find out more…

Filtered By
Stents, scaffolds and DCB

583 results

New trials in coronary imaging and physiology

23 May 2019 – From EuroPCR 2019

Consult this session to learn all about the new trials and studies in coronary imaging and physiology: FFR-Search, ROCK II, HAWKEYE, and more!

New trials in coronary imaging and physiology

Latest clinical and technology update of Firehawk Target eluting stent platform

23 May 2019 – From EuroPCR 2019

Consult this session to discover all about the latest clinical and technology update of Firehawk Target eluting stent platform, the results and insights of Target AC trial 2-year follow-up, and more!

Latest clinical and technology update of Firehawk Target eluting stent platform

Crushed, dislodged and compressed: features of complicated stent deployment - Part 2

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about the features of complicated stent deployment and how to efficiently manage this procedure.

Crushed, dislodged and compressed: features of complicated stent deployment - Part 2

Trials and registries - Managing bleeding risk in search of optimal drug-device synergy

23 May 2019 – From EuroPCR 2019

Consult this session to discover the results of the latest trials and registries for the management of bleeding risk in search of optimal drug-device synergy: ROBOT-ACS, GLOBAL LEADERS, SAFE-A, and more!

Trials and registries - Managing bleeding risk in search of optimal drug-device synergy

Ability to treat diabetic patients: DES + DCB strategy

23 May 2019 – From EuroPCR 2019

Consult this session to get insights about the need for a dedicated drug eluting stent (DES), as well as the benefits of a DES+DCB strategy, for diabetes mellitus (DM) and acute MI (AMI) patients.

Ability to treat diabetic patients: DES + DCB strategy

Exploring evidence and experience with magnesium scaffold Magmaris

23 May 2019 – From EuroPCR 2019

Consult this session on magnesium scaffold Magmaris to learn more about the available data on its clinical use and to review interesting intravascular imaging data after Magmaris implantation.

Exploring evidence and experience with magnesium scaffold Magmaris

Clinical use of intracoronary imaging - EAPCI expert consensus

Tom Johnson talks to Giulio Guagliumi about the EAPCI expert consensus document on intracoronary imaging that he presented at EuroPCR 2019. He explains that the document “acknowledges difficulties we as an interventional community have in understanding how best to apply this exciting technology to ensure the...

Clinical use of intracoronary imaging - EAPCI expert consensus

Contemporary strategies for challenging diseases: optimising treatments with ultrathin strut DES

22 May 2019 – From EuroPCR 2019

Consult this session on ultrathin strut drug-eluting stent to learn more about its role in treating complex lesions and patient types, and to discover contemporary approaches to manage various challenging cases, such as ACS STEMI, CTO, and more!

Contemporary strategies for challenging diseases: optimising treatments with ultrathin strut DES

Ultrathin struts (60µ) for all diameter and lengths of stents, will that improve outcome

22 May 2019 – From EuroPCR 2019

Consult this session to learn more about the new highly deliverable 60 micron Ultrathin biodegradable polymer DES- Supraflex Cruz and how it may address the unmet needs, thanks to up-to-date clinical data.

Ultrathin struts (60µ) for all diameter and lengths of stents, will that improve outcome

Why you should treat your PCI patients with the COMBO Plus stent – Insight from clinical-based evidence

22 May 2019 – From EuroPCR 2019

Consult this session to learn how COMBO Plus stent's unique design meets your clinical requirements, in all comers and high risk populations (ACS, Left Main PCI, etc.).

Why you should treat your PCI patients with the COMBO Plus stent – Insight from clinical-based evidence